R. Fritsch et al., BET-V-1, THE MAJOR BIRCH POLLEN ALLERGEN, AND MAL-D-1, THE MAJOR APPLE ALLERGEN, CROSS-REACT AT THE LEVEL OF ALLERGEN-SPECIFIC T-HELPER CELLS, Journal of allergy and clinical immunology, 102(4), 1998, pp. 679-686
Background: Food allergy to apple is frequent in individuals allergic
to tree pollen. The major allergens of birch, Bet v 1, and apple, Mal
d 1, have been cloned and sequenced and display a high degree of seque
nce identity, Leading to IgE crossreactivity. Objective: We sought to
investigate cross-reactivity between Bet v 1 and Mal d 1 at the level
of allergen-specific T lymphocytes. Methods: PBMCs of 13 patients alle
rgic to birch pollen with oral allergy syndrome to apple were stimulat
ed with rBet v 1 and rMal d 1, respectively, thereby establishing alle
rgen-specific T-cell lines and T-cell clones. rMal d 1-specific T-cell
cultures were tested for reactivity with rBet v 1, and rBet v 1-speci
fic T cells were analyzed for reactivity with apple allergen. Cytokine
production patterns in response to specific stimulation were evaluate
d. A selection of cross-reacting T-cell clones was mapped for epitope
specificity by the use of overlapping Bet v 1- derived peptides. Resul
ts: Nineteen Mal d 1-specific T-cell clones were produced, 79% of whic
h cross-reacted with Bet v 1. Eight of 18 Bet v I-specific T-cell clon
es cross-reacted with Mal d 1. Six peptides representing cross-reactiv
e T-cell epitopes could be identified. The respective fragments from b
irch and apple displayed approximately 50% amino acid identity. Sevent
y percent of the cross-reactive T-cell clones revealed a T-H2-like cyt
okine production pattern. Conclusion: The results indicate that cross-
reactivity between apple and birch pollen Leading to the clinical oral
allergy syndrome occurs not only at the serologic, but also at the ce
llular level.